Key facts
- It has raised $2.0M; the latest was Seed Round ($2.0M) in Sep 2025.
- Notable investors include Avaana Capital, Lubrizol, Rebalance Accelerator.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for BacAlt Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for BacAlt Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BacAlt Biosciences
Developer of green alternatives to harmful polymers intended to transform post-harvest waste into biopolymers. The company offers the conversion of post-harvest waste into eco-friendly polymer substitutes, enabling businesses to use sustainable biopolymers like bacterial cellulose and poly gamma glutamic acid.
- Sector
- Business Products and Services (B2B)
- HQ
- Bangalore, India
- Founded
- 2023
- Employees
- 2
- Website
- bacalt.wordpress.com/
- Ownership
- Privately Held (backing)
BacAlt Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BacAlt Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BacAlt Biosciences in its N-PORT filings yet. We sweep new filings monthly.